In 2021,138,825 people died from COPD in the U.S., making it the sixth overall leading cause of death and the fifth ...
A study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...
TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).
Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...
Company has also raised $12 million in funding led by Lucius Partners NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions, ...
AZD-6793 is under clinical development by AstraZeneca and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).
On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...
Sep. 10, 2024 — A scientific team has created a preclinical blood test to identify adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease ...
Learning how to belly breathe can have a huge impact on your health as it relaxes the body, reduces inflammation and limits ...
Many people’s symptoms worsen during the winter period. “We call this an exacerbation or a flare up, when you get ...